Peter J. Hemmersbach
Position: Professor
Phone: +47 22894368
Email:
Fax: +47 22894151
 

Author network for Peter J. Hemmersbach by COREMINE medical


Publications 2017

Krogh N, Rzeppa S, Dyreborg A, Dehnes Y, Hemmersbach P, Backer V, Hostrup M (2017)
Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation
Med Sci Sports Exerc, 49 (6), 1236-1243
PubMed 28072631

Publications 2016

Dyreborg A, Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
Front Pharmacol, 7, 150
PubMed 27375484

Kreiberg M, Becker V, Jessen S, Rzeppa S, Hemmersbach P, Backer V, Hostrup M (2016)
Influence of exercise in normal and hot ambient conditions on the pharmacokinetics of inhaled terbutaline in trained men
Scand J Med Sci Sports, 27 (7), 692-703
PubMed 27167471

Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysis
Drug Test Anal, 8 (10), 1056-1064
PubMed 26990656

Publications 2015

Bjørner T, Anwar T, Brede WR, Hemmersbach P, Slørdal L (2015)
[A man with a changed appearance]
Tidsskr Nor Laegeforen, 135 (3), 243-5
PubMed 25668542

Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P (2015)
Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples
Drug Test Anal, 7 (11-12), 1025-9
PubMed 26607218

Haase CB, Backer V, Kalsen A, Rzeppa S, Hemmersbach P, Hostrup M (2015)
The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis
Drug Test Anal, 8 (7), 613-20
PubMed 26044066

Rzeppa S, Heinrich G, Hemmersbach P (2015)
Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry
Drug Test Anal, 7 (11-12), 1030-9
PubMed 26472592

Publications 2014

Dehnes Y, Myrvold L, Ström H, Ericsson M, Hemmersbach P (2014)
MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples
Drug Test Anal, 6 (11-12), 1144-50
PubMed 25421537

Hostrup M, Kalsen A, Bangsbo J, Hemmersbach P, Karlsson S, Backer V (2014)
High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men
Eur J Appl Physiol, 114 (12), 2499-508
PubMed 25113095

Hullstein I, Sagredo C, Hemmersbach P (2014)
Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference population
Drug Test Anal, 6 (11-12), 1163-9
PubMed 25388436

Kalsen A, Hostrup M, Karlsson S, Hemmersbach P, Bangsbo J, Backer V (2014)
Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance
J Appl Physiol (1985), 117 (10), 1180-7
PubMed 25257871

Publications 2013

Eibye K, Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2013)
Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations
Med Sci Sports Exerc, 45 (1), 16-22
PubMed 22843108

Hostrup M, Kalsen A, Auchenberg M, Rzeppa S, Hemmersbach P, Bangsbo J, Backer V (2013)
Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes
Drug Test Anal, 6 (6), 528-32
PubMed 24166762

Lund H, Snilsberg AH, Halvorsen TG, Hemmersbach P, Reubsaet L (2013)
Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis
Bioanalysis, 5 (5), 623-30
PubMed 23425277

Publications 2012

Elers J, Hostrup M, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
Urine and serum concentrations of inhaled and oral terbutaline
Int J Sports Med, 33 (12), 1026-33
PubMed 22782385

Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects
Clin J Sport Med, 22 (2), 140-5
PubMed 22388343

Hemmersbach P, Drange M, Rabin O, Botrè F, Dehnes Y (2012)
Doping analysis on solid ground
Tidsskr Nor Laegeforen, 132 (2), 130
PubMed 22278263

Lund H, Snilsberg AH, Paus E, Halvorsen TG, Hemmersbach P, Reubsaet L (2012)
Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males
Anal Bioanal Chem, 405 (5), 1569-76
PubMed 23203507

Publications 2011

Dehnes Y, Hemmersbach P (2011)
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters
Drug Test Anal, 3 (5), 291-9
PubMed 21387570

Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2011)
Urine concentrations of repetitive doses of inhaled salbutamol
Int J Sports Med, 32 (8), 574-9
PubMed 21563035

Hemmersbach P (2011)
The 29th Manfred Donike workshop on doping analysis
Drug Test Anal, 3 (11-12), 755
PubMed 22213683

Publications 2010

Elers J, Pedersen L, Henninge J, Lund TK, Hemmersbach P, Dalhoff K, Backer V (2010)
Blood and urinary concentrations of salbutamol in asthmatic subjects
Med Sci Sports Exerc, 42 (2), 244-9
PubMed 19927035

Hemmersbach P, Grosse J (2010)
Nandrolone: a multi-faceted doping agent
Handb Exp Pharmacol (195), 127-54
PubMed 20020363

Henninge J, Pepaj M, Hullstein I, Hemmersbach P (2010)
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation
Drug Test Anal, 2 (11-12), 647-50
PubMed 21204297

Publications 2009

Thevis M, Hemmersbach P, Geyer H, Schänzer W (2009)
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]
Med Klin (Munich), 104 (12), 918-24
PubMed 20039158

Publications 2008

Hemmersbach P (2008)
History of mass spectrometry at the Olympic Games
J Mass Spectrom, 43 (7), 839-53
PubMed 18570181

Hintikka L, Kuuranne T, Leinonen A, Thevis M, Schänzer W, Halket J, Cowan D, Grosse J, Hemmersbach P, Nielen MW, Kostiainen R (2008)
Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison
J Mass Spectrom, 43 (7), 965-73
PubMed 18563858

Juul A, Sørensen K, Aksglaede L, Garn I, Rajpert-De Meyts E, Hullstein I, Hemmersbach P, Ottesen AM (2008)
A common deletion in the uridine diphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys
J Clin Endocrinol Metab, 94 (3), 1005-11
PubMed 19088161

Publications 2007

Morkeberg J, Lundby C, Nissen-Lie G, Nielsen TK, Hemmersbach P, Damsgaard R (2007)
Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation
Med Sci Sports Exerc, 39 (10), 1742-7
PubMed 17909401

Publications 2006

Hemmersbach P, Hågensen Jetne AH, Lund HS (2006)
Determination of urinary norandrosterone excretion in females during one menstrual cycle by gas chromatography/mass spectrometry
Biomed Chromatogr, 20 (8), 710-7
PubMed 16229056

Publications 2005

Grosse J, Anielski P, Hemmersbach P, Lund H, Mueller RK, Rautenberg C, Thieme D (2005)
Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples
Steroids, 70 (8), 499-506
PubMed 15894033

Publications 2004

Hemmersbach P (2004)
New analytical challenges in doping control. The situation after the Olympic Games in Athens
Med. Sport, 57 (3), 278

Nissen-Lie G, Birkeland K, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control
Med Sci Sports Exerc, 36 (4), 588-93
PubMed 15064585

Publications 2000

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
Med Sci Sports Exerc, 32 (7), 1238-43
PubMed 10912888

Publications 1999

Birkeland KI, Hemmersbach P (1999)
The future of doping control in athletes. Issues related to blood sampling
Sports Med, 28 (1), 25-33
PubMed 10461710

Haug E, Hemmersbach P, Birkeland K (1999)
[Glimpses from the history of doping in sports]
Tidsskr Nor Laegeforen, 119 (17), 2538-40
PubMed 10425911

Publications 1998

Reubsaet KJ, Ragnar Norli H, Hemmersbach P, Rasmussen KE (1998)
Determination of benzodiazepines in human urine and plasma with solvent modified solid phase micro extraction and gas chromatography; rationalisation of method development using experimental design strategies
J Pharm Biomed Anal, 18 (4-5), 667-80
PubMed 9919968

Tomten SE, Falch JA, Birkeland KI, Hemmersbach P, Høstmark AT (1998)
Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior
Int J Sports Med, 19 (2), 92-7
PubMed 9562216

Publications 1997

Birkeland KI, Donike M, Ljungqvist A, Fagerhol M, Jensen J, Hemmersbach P, Oftebro H, Haug E (1997)
Blood sampling in doping control. First experiences from regular testing in athletics
Int J Sports Med, 18 (1), 8-12
PubMed 9059898

Segura J, Hemmersbach P, Sonksen P (1997)
Sports drug testing - A report on the 1st International Symposium on Advances in Dope Testing Research, held in Lausanne, Switzerland, 22-23 April 1997.
Trac-Trends Anal. Chem., 16 (7), R6-R7

Publications 1996

Haug E, Birkeland KI, Hemmersbach P (1996)
[Doping legislation]
Tidsskr Nor Laegeforen, 116 (2), 297-8
PubMed 8633342

Hemmersbach P, de la Torre R (1996)
Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control
J Chromatogr B Biomed Appl, 687 (1), 221-38
PubMed 9001968

Publications 1995

Norli HR, Esbensen K, Westad F, Birkeland KI, Hemmersbach P (1995)
Chemometric evaluation of urinary steroid profiles in doping control
J Steroid Biochem Mol Biol, 54 (1-2), 83-8
PubMed 7632620

Publications 1994

Birkeland KI, Jørgensen J, Hemmersbach P (1994)
[Endocrine effects of doping with androgenic anabolic steroids]
Tidsskr Nor Laegeforen, 114 (4), 426-8
PubMed 8009475